Full-automatic chemiluminescence immunity analyzer

Abstract

A full-automatic chemiluminescence immunity analyzer comprises a frame, a transferring system, a sampling system, an incubation system, a cleaning system, an optical detection system and a control system. The transferring system comprises a cup feeding mechanism, a cup inlet and a grasping mechanism; the sampling system comprises a sample tray, a reagent tray, a sample adding mechanism and two first driving sources; the incubation system comprises an incubation tray, a second driving source and a mixing mechanism; the cleaning system comprises a cleaning plate and a third driving source; the optical detection system comprises photometric plate and an optical collection mechanism. When sample analysis is required, the full-automatic chemiluminescence immunity analyzer is started and controlled to operate by the control system, and then the transferring system, the sampling system, the incubation system, the cleaning system and the optical detection system operate correspondingly, so that all operations are automatic operations. The full-automatic chemiluminescence immunity analyzer has advantages that probabilistic problems including individual differences, manual errors, operational nonuniformity and the like of manual operations are avoided effectively, and accuracy in chemiluminescence immunity analysis is improved.

Description

technical field [0001] The invention relates to the technical field of chemiluminescence immunoassay devices, in particular to a fully automatic chemiluminescence immunoassay analyzer. Background technique [0002] Chemiluminescent immunoassay has the advantages of high sensitivity, strong specificity, wide linear range, and high degree of automation, and has become the main means of clinical diagnosis. However, domestic automatic chemiluminescence immunoassays started relatively late, but clinical applications developed rapidly. At first, only test items such as sex hormones and thyroid hormones were detected by chemiluminescence. With the further development of technology, tumor markers, metabolic substances, There are more and more detectable items such as infectious disease markers and cardiovascular and cerebrovascular disease markers. At the same time, chemiluminescence immunoassay also has its uncertainties, which mainly come from the experimental operation and detect...

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to overcome the defects of the prior art and provide a fully automatic chemiluminescence immunoassay analyzer with a high degree of automation and fast and accurate detection speed, so as to solve the problem that the chemiluminescence immunoassay analyzer in the prior art can only realize the detection reading value Functional and manual operations have uncertainties such as individual differences, manual errors, and operating specifications

Images